EAGLE, Idaho - The Pennant Group, Inc. (NASDAQ: PNTG), a network of home health, hospice, and senior living services, has announced changes to its board of directors, with the promotion of two existing members to key leadership positions, effective January 1, 2025. The company, currently valued at $908 million, has shown remarkable performance with an 87% stock return over the past year. According to InvestingPro, the company maintains a strong financial health score, with analysts expecting continued net income growth.
Brent Guerisoli, who has been part of Pennant’s board since 2023 and served as the company’s CEO since 2022, has been named the new Chairman of the board. He replaces Barry Smith, who has held the position since February 2023. Smith praised Guerisoli’s leadership and performance, expressing confidence in his ability to guide the company forward. Under their leadership, Pennant has achieved impressive revenue growth of 25% and maintains a solid Piotroski Score of 8, indicating strong operational efficiency. Smith will continue serving on the board and as the chairman of the nominating and corporate governance committee.
Additionally, Scott Lamb has been appointed as the Lead Independent (LON:IOG) Director. Lamb, a member of Pennant’s board since 2019 and chairman of its audit committee, previously served as the CFO of ICU Medical (NASDAQ:ICUI), Inc. from 2008 to 2020. His extensive experience in finance and leadership within the medical industry is expected to provide significant influence on board decisions and ensure active participation of the independent directors. For detailed analysis of Pennant’s leadership changes and financial metrics, access the comprehensive Pro Research Report available on InvestingPro.
Pennant operates 122 home health and hospice agencies and 57 senior living communities across 14 states, each managed by separate, independent subsidiaries. The company emphasizes that references to the consolidated "company" do not imply direct operational control over the individual subsidiaries.
This announcement is based on a press release statement from The Pennant Group, Inc.
In other recent news, The Pennant Group has reported significant growth in its Q3 2024 earnings and revenue results. The company’s total revenue reached $180.7 million, marking a 28.9% increase from the previous year, while adjusted earnings per share saw a substantial rise of 30% to $0.26. The Home Health and Hospice segment, along with the Senior Living segment, were key drivers of this growth.
The Pennant Group has also recently announced a partnership with Kno2, a leader in healthcare communication technology. The collaboration aims to advance patient care in home settings by improving data interoperability. As part of this partnership, Pennant Group will join Kno2’s Qualified Health Information Network, enhancing the exchange of health information across its network of home health, hospice, and senior living companies.
In addition to these recent developments, The Pennant Group continues to expand through acquisitions, including three Senior Living communities in Northern Wisconsin and the Washington and Idaho assets of Signature Healthcare at Home. The company is also set to close on the Oregon assets of Signature Healthcare at Home soon. Despite facing challenges such as rising labor costs and flat Medicare reimbursement rates, Pennant maintains a strong capital position with zero debt. The company’s operating margin improved significantly from 4.6% in Q3 2022 to 9.8% in Q3 2024.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.